Cardiology Cardiac Surgery
EuroSCORE II
European System for Cardiac Operative Risk Evaluation II. Estimates operative mortality risk for adult cardiac surgery. Updated model from EuroSCORE I with improved calibration.
Score interpretation
Predicted Mortality < 2 % 0–1.99
EuroSCORE II predicted in-hospital mortality below 2 %.
→ Standard heart-team planning.
Predicted Mortality 2–5 % 2–5
EuroSCORE II predicted in-hospital mortality 2–5 %.
→ Discuss risk and benefit; heart-team review.
Predicted Mortality > 5 % 5.01–100
EuroSCORE II predicted in-hospital mortality above 5 %.
→ Heart-team review of options, including non-surgical.
Interpretation bands for the EuroSCORE II. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Protamine Sulphate (Heparin Reversal) · Heparin Reversal / Cardiac Surgery
- Aprotinin · Antifibrinolytic — Cardiac Surgery
- Protamine Sulphate · Heparin Antidote — Vascular / Cardiac Surgery
- Tranexamic Acid (ICU/Trauma/Surgical) · Antifibrinolytic
- Lidocaine IV (Cardiac Arrhythmia) · Antiarrhythmic
- Mavacamten · Cardiac myosin inhibitor
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.
